Kexing BiopharmEN
Home / Our Medicines / Adalimumab Solution for Injection / Adalimumab Solu...

Adalimumab Solution for Injection

Adalimumab Solution for Injection

Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.

Blockbuster drugs in the field of autoimmune diseases, and the highest sales volume in China

Adalimumab(Ahrasin) is a fully human anti-tumor necrosis factor-α(TNF-α) monoclonal antibaby, a biosimilar drug of HUMIRA. Excessive inflammation in a variety of immune-mediated diseases in humans are associated with TNF-α.


Rheumatoid Arthritis; Ankylosing spondylitis; Psoriasis; Crohn's disease; Uveitis; Polyarticular juvenile idiopathic arthritis ;Plaque psoriasis in children;Crohn's disease in children

Recommended reading:

Adalimumab Biosimilar: A Promising Alternative to Expensive Biologics

Adalimumab Biosimilars: Advancing Healthcare Access with Kexing Biopharm